Publications

In Vitro Activity of Ceftaroline Tested against Bacterial Pathogens Frequently Isolated in United States Medical Centers: Results from the AWARE Surveillance Program, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary Pathogens Isolated from Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Lead author: Farrell DJ, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary Pathogens Isolated from Patients with Community-Acquired Bacterial Pneumonia (CABP), Lead author: Farrell DJ, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Assessment of Oritavancin Activity Tested against Gram-positive Bacteria from USA and European Medical Centers over a Three-year Period (2008 – 2010), Lead author: Mendes RE, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Update on Telavancin Activity Tested Against a Global Collection of Gram-positive Pathogens (2010), Lead author: Mendes RE, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Antimicrobial Activity of BC-3781, an Investigational Pleuromutilin, Tested Against Organisms Isolated From Patients with Community-Acquired Respiratory Tract Infections, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Analysis of the Molecular Epidemiology of Staphylococcus epidermidis Clinical Isolates from USA Hospitals, Lead author: Mendes RE, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Occurrence of NDM-1 and other carbapenemases among Acinetobacter spp. and Pseudomonas spp. Collected from India, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

A Multi-Site Evaluation to Determine the Performance of the Sensititre YeastOne Susceptibility System using the Sensititre Vizion Compared to a Mirror Read Method, Lead author: Holliday, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Potency of Dalbavancin Tested Against 37,258 Gram-positive Cutaneous Pathogens from USA Medical Centers (2006-2009), Lead author: Jones RN, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Antimicrobial Activity of Daptomycin in Comparison to Glycopeptides and Other Antimicrobials When Tested against Numerous Species of Coagulase-negative Staphylococcus (CoNS), Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

In Vitro Activity of Ceftazidime/NXL104 Against Pathogens Collected During a Phase II Complicated Urinary Tract infection (cUTI) Clinical Trial, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Activity of AFN-1252, a FabI Inhibitor with Potent Activity against S. aureus and Coagulase-Negative Staphylococcus spp. (CoNS), Including Multidrug-Resistant Strains, Lead author: Biedenbach DJ, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Antimicrobial Activity of Four Oxazolidinone Investigational Compounds Tested against a Collection of Linezolid-non-susceptible Strains with Genetically Defined Resistance Mechanisms, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

In vitro Activity of a Novel Broad-spectrum Antifungal Agent, E1210, and Comparators Tested against Candida spp., Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Pre-clinical Development of Susceptibility Testing Methods for the Novel Antifungal E1210 Tested against Candida: Comparison of CLSI and EUCAST Methods, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

In vitro Activity of a Novel Broad-spectrum Antifungal, E1210, Tested against Aspergillus spp. By CLSI and EUCAST Broth Microdilution Methods, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Profile of Staphylococcus aureus Isolated from United States (USA) Pediatric Patients During the 2009 Ceftaroline AWARE Surveillance Program, Lead author: Krause, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Evaluation of Pneumococci Isolated from United States (USA) Pediatric Patients During the 2009 AWARE Program, Lead author: Krause, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Molecular Identification of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Program, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Declining MRSA and Fluoroquinolone Resistance Rates Among S. aureus (SA) in the USA: Report from the SENTRY Antimicrobial Surveillance Program (2000–2009), Lead author: Jones RN, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Surveillance of Linezolid Activity against Staphylococci in the United States (USA 2010), Lead author: Ross JE, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Analysis of Linezolid Resistance Mechanisms and Epidemiology of Cfr-producing Strains in the United States, Lead author: Mendes RE, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Carbapenemase Production in United States (USA) Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2009), Lead author: Castanheira M, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

In Vitro Activity Of Anidulafungin and Voriconazole, and Comparators Against Aspergillus spp. as Determined By CLSI And EUCAST Broth Microdilution Methods, Lead author: Pfaller MA, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

An Evaluation of the New Sensititre AIM Performance Compared to the Existing Sensititre Autoinoculator for MIC Determination, Lead author: Killian SB, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

An Evaluation of the New Sensititre OptiRead Performance Compared to the Existing Sensititre AutoReader for MIC Determination, Lead author: Holliday, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Antimicrobial Activity of Daptomycin Tested Against S. aureus Collected from Osteoarticular Infections, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Comparison of Tigecycline Activity Tested against Multidrug-resistant Bacteria Isolated from European Medical Centres in Two Time Periods: 2003-2005 and 2008-2010, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Dalbavancin Surveillance Results for European Gram-positive Species (2006-2009) in a Contemporary Sample of 23,825 Strains, Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Analysis of Oritavancin Activity Tested against a Challenge Set of Staphylococcus aureus from Europe (2008-2010), Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Potency of radezolid (RX-1741) and torezolid (DA-7157) tested against a collection of linezolid-non-susceptible strains with genetically defined resistant mechantisms, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity of Solithromycin (CEM-101), a Novel Fluoroketolide Tested against Isolates Collected in Europe during 2010 Surveillance, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Community-Acquired Bacterial Pneumonia, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Acute Bacterial Skin and Skin-Structure Infections, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of PF-1 and PF-2, Novel Siderophore Conjugated Beta-lactams, Tested Against Enterobacteriaceae Strains Carrying Emerging Resistance Mechanisms, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity and Spectrum of Doripenem against Contemporary (2010) Clinical Bacterial Pathogens from Europe, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Linezolid Susceptibility in Europe for 2010: ZAAPS Program (5,532 strains), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of Ceftaroline and Comparator Agents Tested Against Organisms Responsible for Community-Acquired Respiratory Tract Infections in Europe (2009), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Association of 16S rRNA Methylases and NDM-1 in Isolates from Indian Hospitals Collected in 2006-2007, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

IMP-18-Producing Klebsiella oxytoca, Increasing Genetic Diversity of Metallo-beta-Lactamases in Mexican Hospitals, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Genotypic Evaluation of a Collection of Cfr-producing Staphylococcal Clinical Isolates from the SENTRY Antimicrobial Surveillance Program., Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

NDM-1 in Israel, Evidence of Traveling and Carriage of Carbapenem-Resistant Organisms, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Evaluation of quinolone resistance determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

EUCAST MIC breakpoints and inhibition zone diameter correlates for staphylococci, Lead author: Matuschek, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Susceptibility of Enterococci and Streptococci from United States (USA) Hospitals: A 9-Year Summary of the Daptomycin Surveillance Program (2002-2010), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial activity and spectrum of daptomycin tested against Gram-positive strains collected in European hospitals: Results from 7 years of surveillance (2003-2009), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Fusidic Acid Activity and Coverage of Gram-positive Pathogens Associated with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the USA (2008-2010), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity of Ceftaroline Tested Against Common Pathogens Causing Complicated Skin and Soft Tissue Infections in European Medical Centres in 2009, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Comprehensive analysis of telavancin activity against staphylococcal isolates from Europe (2009-2010), including strains with reduced susceptibility to vancomycin, Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy